Gene Symbol | Gene ID | Gene Info |
---|---|---|
Plag1
|
ENSMUSG00000003282.3 | pleiomorphic adenoma gene 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_3920813_3920967 | Plag1 | 17492 | 0.125979 | -0.52 | 4.9e-05 | Click! |
chr4_3938048_3938202 | Plag1 | 257 | 0.789047 | 0.42 | 1.2e-03 | Click! |
chr4_3929988_3930164 | Plag1 | 8306 | 0.140154 | 0.41 | 1.8e-03 | Click! |
chr4_3936788_3936939 | Plag1 | 1519 | 0.281510 | 0.22 | 9.9e-02 | Click! |
chr4_3936512_3936722 | Plag1 | 1765 | 0.251199 | 0.20 | 1.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14350947_14351733 | 38.42 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr3_88205532_88206477 | 37.43 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr16_44687184_44688343 | 36.57 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr12_3236518_3237725 | 35.38 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr8_70315603_70316677 | 33.69 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr15_98004283_98005074 | 32.91 |
Col2a1 |
collagen, type II, alpha 1 |
17 |
0.97 |
chr16_44530838_44531222 | 31.34 |
Mir3081 |
microRNA 3081 |
27099 |
0.17 |
chr4_136835920_136836937 | 31.22 |
Ephb2 |
Eph receptor B2 |
440 |
0.83 |
chr19_61225302_61226760 | 30.17 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr8_4492910_4494136 | 29.51 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr8_122284023_122284944 | 29.17 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chrX_135795471_135796247 | 26.84 |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
1729 |
0.22 |
chr18_25678986_25679896 | 26.61 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
34329 |
0.19 |
chr7_62231071_62231594 | 26.22 |
Gm9801 |
predicted gene 9801 |
21853 |
0.21 |
chr9_49796724_49798126 | 25.58 |
Ncam1 |
neural cell adhesion molecule 1 |
1333 |
0.53 |
chr5_150593023_150594879 | 25.23 |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
182 |
0.88 |
chr10_81559146_81561402 | 24.22 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr3_108085301_108086522 | 23.75 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr6_55451539_55452374 | 23.37 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
22 |
0.98 |
chr18_21653019_21653700 | 23.27 |
4930426D05Rik |
RIKEN cDNA 4930426D05 gene |
796 |
0.5 |
chr7_19176285_19176869 | 22.91 |
Eml2 |
echinoderm microtubule associated protein like 2 |
156 |
0.88 |
chr8_4206127_4207837 | 22.77 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr5_37716863_37717819 | 22.65 |
Stk32b |
serine/threonine kinase 32B |
170 |
0.96 |
chr7_19749021_19749968 | 22.62 |
Nectin2 |
nectin cell adhesion molecule 2 |
39 |
0.93 |
chr7_6727792_6729098 | 22.44 |
Peg3 |
paternally expressed 3 |
1974 |
0.16 |
chr7_4995595_4996371 | 22.29 |
Zfp579 |
zinc finger protein 579 |
46 |
0.92 |
chr2_105680597_105681214 | 22.18 |
Pax6 |
paired box 6 |
807 |
0.59 |
chr17_55985980_55986972 | 21.66 |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
33 |
0.94 |
chr2_157464727_157465479 | 21.42 |
Src |
Rous sarcoma oncogene |
8018 |
0.18 |
chr9_26733143_26733768 | 21.30 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
273 |
0.88 |
chr9_108587464_108588439 | 21.22 |
Gm49209 |
predicted gene, 49209 |
899 |
0.26 |
chr4_22488420_22489023 | 21.21 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
355 |
0.83 |
chr1_74858050_74858726 | 20.97 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
3454 |
0.13 |
chr3_108433472_108434154 | 20.91 |
Gm22942 |
predicted gene, 22942 |
7517 |
0.09 |
chr13_34129793_34130880 | 20.87 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr14_14347096_14348750 | 20.80 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr10_78747019_78747870 | 20.72 |
Gm30400 |
predicted gene, 30400 |
285 |
0.85 |
chr19_38054215_38055320 | 20.57 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr7_43490136_43490673 | 20.39 |
Iglon5 |
IgLON family member 5 |
329 |
0.72 |
chr2_33130296_33131698 | 20.27 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr8_12915219_12915955 | 20.19 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr9_40268412_40269319 | 20.11 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr12_3834339_3834973 | 20.08 |
Dnmt3a |
DNA methyltransferase 3A |
14979 |
0.17 |
chr5_23675895_23676511 | 19.92 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
152 |
0.84 |
chr9_86879639_86880662 | 19.88 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr16_33605736_33606716 | 19.79 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr1_92847829_92849060 | 19.68 |
Gm29480 |
predicted gene 29480 |
327 |
0.77 |
chr9_107629988_107631141 | 19.59 |
Gm19721 |
predicted gene, 19721 |
1975 |
0.12 |
chr4_109977849_109978740 | 19.46 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
241 |
0.73 |
chr7_24486952_24487542 | 19.29 |
Cadm4 |
cell adhesion molecule 4 |
5224 |
0.09 |
chr12_112721309_112722969 | 19.25 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr7_44310178_44311500 | 19.20 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr2_94273064_94274137 | 19.16 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr10_87493217_87493966 | 19.02 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
69 |
0.97 |
chr10_127620769_127621196 | 18.79 |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
12 |
0.95 |
chr2_178141291_178141933 | 18.58 |
Phactr3 |
phosphatase and actin regulator 3 |
321 |
0.92 |
chr18_58835866_58837093 | 18.31 |
Adamts19 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19 |
188 |
0.97 |
chr2_109677143_109677796 | 18.10 |
Bdnf |
brain derived neurotrophic factor |
437 |
0.68 |
chrX_134686235_134686690 | 18.08 |
B230119M05Rik |
RIKEN cDNA B230119M05 gene |
0 |
0.52 |
chr9_37453861_37454564 | 17.91 |
Robo3 |
roundabout guidance receptor 3 |
20966 |
0.1 |
chr17_45548642_45549512 | 17.69 |
Tmem151b |
transmembrane protein 151B |
600 |
0.55 |
chr2_127521161_127522051 | 17.68 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr7_40898695_40899783 | 17.68 |
Vstm2b |
V-set and transmembrane domain containing 2B |
39 |
0.91 |
chr10_80145825_80146996 | 17.65 |
Midn |
midnolin |
1862 |
0.15 |
chr3_94477953_94478530 | 17.65 |
Celf3 |
CUGBP, Elav-like family member 3 |
54 |
0.93 |
chr5_138948065_138948968 | 17.39 |
Pdgfa |
platelet derived growth factor, alpha |
45765 |
0.12 |
chr11_32220828_32222435 | 17.35 |
Rhbdf1 |
rhomboid 5 homolog 1 |
613 |
0.58 |
chr16_42575508_42575977 | 17.19 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr2_151970289_151970825 | 17.10 |
Fam110a |
family with sequence similarity 110, member A |
2837 |
0.17 |
chr2_16355572_16356406 | 17.07 |
Plxdc2 |
plexin domain containing 2 |
315 |
0.95 |
chrX_13346707_13347908 | 16.88 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr1_42695117_42695493 | 16.76 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
380 |
0.35 |
chr11_98963166_98964309 | 16.66 |
Rara |
retinoic acid receptor, alpha |
3325 |
0.14 |
chrX_73064116_73064579 | 16.66 |
Pnma3 |
paraneoplastic antigen MA3 |
440 |
0.69 |
chr14_24578363_24578849 | 16.64 |
4930542C16Rik |
RIKEN cDNA 4930542C16 gene |
38698 |
0.14 |
chr11_114704064_114704547 | 16.62 |
Dnaic2 |
dynein, axonemal, intermediate chain 2 |
23103 |
0.13 |
chrX_58038370_58038794 | 16.61 |
Zic3 |
zinc finger protein of the cerebellum 3 |
7572 |
0.26 |
chr1_74284190_74285456 | 16.57 |
Aamp |
angio-associated migratory protein |
85 |
0.51 |
chr3_108423860_108424486 | 16.50 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
8621 |
0.09 |
chr8_87837276_87837611 | 16.48 |
Zfp423 |
zinc finger protein 423 |
33004 |
0.22 |
chr5_24482511_24483721 | 16.46 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
2944 |
0.12 |
chr1_34665546_34665842 | 16.45 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
12494 |
0.12 |
chr2_32317120_32318698 | 16.35 |
Gm23363 |
predicted gene, 23363 |
356 |
0.45 |
chr1_93210132_93210761 | 16.35 |
Sned1 |
sushi, nidogen and EGF-like domains 1 |
25395 |
0.11 |
chr11_96899438_96899874 | 16.21 |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
9102 |
0.09 |
chr2_180890526_180891097 | 16.20 |
Gm14342 |
predicted gene 14342 |
1151 |
0.29 |
chr13_49370675_49371884 | 16.16 |
Bicd2 |
BICD cargo adaptor 2 |
11810 |
0.19 |
chr14_118812628_118813057 | 16.15 |
n-R5s51 |
nuclear encoded rRNA 5S 51 |
14189 |
0.15 |
chrX_135838588_135838853 | 16.07 |
Gprasp2 |
G protein-coupled receptor associated sorting protein 2 |
314 |
0.87 |
chr10_81429712_81431957 | 15.97 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr17_25809079_25809913 | 15.97 |
Fbxl16 |
F-box and leucine-rich repeat protein 16 |
411 |
0.54 |
chr8_102784788_102785524 | 15.92 |
Cdh11 |
cadherin 11 |
486 |
0.8 |
chr2_173658978_173659962 | 15.83 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr19_7265678_7266564 | 15.79 |
Rcor2 |
REST corepressor 2 |
1204 |
0.3 |
chr3_34649198_34650117 | 15.79 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr10_13117108_13117586 | 15.72 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
983 |
0.59 |
chr2_84742105_84743284 | 15.66 |
Gm19426 |
predicted gene, 19426 |
961 |
0.29 |
chr5_128599236_128600028 | 15.66 |
Fzd10os |
frizzled class receptor 10, opposite strand |
1022 |
0.34 |
chr13_91915980_91916295 | 15.60 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
39252 |
0.15 |
chr1_190728840_190729282 | 15.54 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
81402 |
0.09 |
chr15_89498976_89499718 | 15.52 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
276 |
0.79 |
chr10_81364518_81366962 | 15.51 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr3_114029993_114030781 | 15.50 |
Col11a1 |
collagen, type XI, alpha 1 |
153 |
0.98 |
chrX_102003725_102004324 | 15.49 |
Nhsl2 |
NHS-like 2 |
1020 |
0.5 |
chr17_8800581_8801529 | 15.41 |
Pde10a |
phosphodiesterase 10A |
638 |
0.79 |
chr8_123514747_123515742 | 15.40 |
Dbndd1 |
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
146 |
0.78 |
chr12_111693687_111693960 | 15.15 |
Gm36635 |
predicted gene, 36635 |
9259 |
0.09 |
chr1_173367143_173367780 | 15.14 |
Cadm3 |
cell adhesion molecule 3 |
172 |
0.94 |
chr2_33215438_33216087 | 15.13 |
Angptl2 |
angiopoietin-like 2 |
307 |
0.87 |
chr1_75381745_75382746 | 15.11 |
Speg |
SPEG complex locus |
107 |
0.93 |
chr18_25582908_25583396 | 15.10 |
Gm3227 |
predicted gene 3227 |
14338 |
0.27 |
chr10_81472309_81472908 | 15.09 |
Celf5 |
CUGBP, Elav-like family member 5 |
394 |
0.64 |
chr15_103339347_103340247 | 15.08 |
Zfp385a |
zinc finger protein 385A |
296 |
0.82 |
chr6_28842333_28842923 | 15.07 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
6279 |
0.2 |
chr2_28525282_28526472 | 15.05 |
Ralgds |
ral guanine nucleotide dissociation stimulator |
1973 |
0.2 |
chr7_44593726_44594565 | 15.04 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
150 |
0.87 |
chr1_3671269_3672324 | 14.98 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr7_137316861_137317678 | 14.89 |
Ebf3 |
early B cell factor 3 |
2824 |
0.26 |
chr11_17460047_17460676 | 14.87 |
Gm12015 |
predicted gene 12015 |
161942 |
0.03 |
chr2_152094889_152095634 | 14.82 |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
10255 |
0.13 |
chr4_54948675_54949554 | 14.81 |
Zfp462 |
zinc finger protein 462 |
1138 |
0.62 |
chrX_150812603_150813957 | 14.80 |
Maged2 |
melanoma antigen, family D, 2 |
126 |
0.95 |
chr14_12822580_12823213 | 14.78 |
Cadps |
Ca2+-dependent secretion activator |
149 |
0.97 |
chr7_79531898_79532317 | 14.73 |
Gm35040 |
predicted gene, 35040 |
3936 |
0.11 |
chr2_102451171_102452295 | 14.71 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr6_39871998_39872940 | 14.70 |
Gm26833 |
predicted gene, 26833 |
498 |
0.51 |
chr12_14089126_14089342 | 14.66 |
Gm48482 |
predicted gene, 48482 |
41414 |
0.15 |
chr7_18893553_18894193 | 14.60 |
Ccdc61 |
coiled-coil domain containing 61 |
86 |
0.94 |
chr12_79911112_79911786 | 14.60 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
13284 |
0.2 |
chr14_54912471_54913268 | 14.55 |
Slc22a17 |
solute carrier family 22 (organic cation transporter), member 17 |
21 |
0.93 |
chr6_127768794_127769871 | 14.50 |
Prmt8 |
protein arginine N-methyltransferase 8 |
140 |
0.91 |
chr7_79578006_79578675 | 14.48 |
Gm45168 |
predicted gene 45168 |
728 |
0.49 |
chr1_42687059_42687229 | 14.44 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
5949 |
0.15 |
chr5_108549866_108550582 | 14.43 |
Cplx1 |
complexin 1 |
200 |
0.9 |
chr3_19406344_19406802 | 14.41 |
Pde7a |
phosphodiesterase 7A |
95251 |
0.07 |
chr15_89453930_89454500 | 14.37 |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
302 |
0.77 |
chr7_16129395_16130325 | 14.37 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
34 |
0.96 |
chr10_13982761_13983386 | 14.36 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16049 |
0.19 |
chr17_23675766_23677157 | 14.34 |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
92 |
0.89 |
chr7_79572141_79572757 | 14.31 |
Gm45168 |
predicted gene 45168 |
6619 |
0.1 |
chr8_87938327_87939174 | 14.24 |
Zfp423 |
zinc finger protein 423 |
5302 |
0.29 |
chr7_29169567_29170563 | 14.23 |
Ggn |
gametogenetin |
145 |
0.58 |
chr10_58227289_58228680 | 14.21 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr9_110249742_110250130 | 14.16 |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
3871 |
0.14 |
chr18_79049027_79050094 | 14.14 |
Setbp1 |
SET binding protein 1 |
59831 |
0.15 |
chr14_7314343_7315443 | 14.09 |
Gm3739 |
predicted gene 3739 |
156 |
0.94 |
chr13_83732174_83732508 | 14.02 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
225 |
0.89 |
chr3_73056881_73057482 | 13.97 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr2_121295300_121295921 | 13.94 |
Map1a |
microtubule-associated protein 1 A |
147 |
0.76 |
chr17_73540417_73540579 | 13.83 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
1547 |
0.37 |
chr5_112041311_112041693 | 13.83 |
Gm42488 |
predicted gene 42488 |
97267 |
0.07 |
chr13_59092007_59092498 | 13.80 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
8159 |
0.17 |
chr15_99456957_99458276 | 13.74 |
Nckap5l |
NCK-associated protein 5-like |
96 |
0.93 |
chr9_20642226_20643132 | 13.72 |
Fbxl12 |
F-box and leucine-rich repeat protein 12 |
127 |
0.59 |
chrX_150656766_150657291 | 13.68 |
Tro |
trophinin |
344 |
0.86 |
chr7_117618711_117618903 | 13.66 |
Xylt1 |
xylosyltransferase 1 |
143315 |
0.05 |
chr4_98395493_98396474 | 13.64 |
Patj |
PATJ, crumbs cell polarity complex component |
91 |
0.96 |
chrX_150657314_150657521 | 13.60 |
Tro |
trophinin |
18 |
0.97 |
chr11_88481574_88481837 | 13.57 |
Gm11510 |
predicted gene 11510 |
48191 |
0.14 |
chr9_61872624_61872918 | 13.57 |
Gm19208 |
predicted gene, 19208 |
21067 |
0.18 |
chr2_33593309_33593623 | 13.54 |
Gm38011 |
predicted gene, 38011 |
20932 |
0.15 |
chr2_105674521_105675719 | 13.50 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr12_53248103_53248294 | 13.48 |
Npas3 |
neuronal PAS domain protein 3 |
41 |
0.99 |
chr4_120259665_120260065 | 13.44 |
Foxo6 |
forkhead box O6 |
27484 |
0.18 |
chr18_25600297_25600916 | 13.41 |
Gm3227 |
predicted gene 3227 |
3116 |
0.36 |
chr5_137734700_137735086 | 13.39 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
4825 |
0.1 |
chr9_106464770_106466154 | 13.33 |
Gpr62 |
G protein-coupled receptor 62 |
476 |
0.6 |
chr14_7026815_7027118 | 13.31 |
Gm10406 |
predicted gene 10406 |
483 |
0.74 |
chr8_84945228_84946066 | 13.29 |
Rtbdn |
retbindin |
1344 |
0.18 |
chr7_79497714_79498195 | 13.28 |
Mir9-3hg |
Mir9-3 host gene |
2072 |
0.16 |
chr7_79504714_79505014 | 13.26 |
Mir9-3 |
microRNA 9-3 |
400 |
0.7 |
chr4_141425494_141426465 | 13.26 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
5200 |
0.1 |
chr7_30291145_30292058 | 13.26 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
127 |
0.89 |
chr9_83805509_83806110 | 13.24 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
443 |
0.84 |
chr3_88228020_88228365 | 13.23 |
Gm3764 |
predicted gene 3764 |
376 |
0.69 |
chr6_29434887_29435275 | 13.21 |
Flnc |
filamin C, gamma |
1805 |
0.2 |
chr4_81727500_81727721 | 13.18 |
Gm11412 |
predicted gene 11412 |
15536 |
0.24 |
chr10_23349524_23350360 | 13.18 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
39 |
0.99 |
chr6_136173009_136173858 | 13.17 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
56 |
0.85 |
chr12_111758304_111760062 | 13.17 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr15_27779819_27780020 | 13.17 |
Trio |
triple functional domain (PTPRF interacting) |
8719 |
0.24 |
chr15_32172538_32172721 | 13.14 |
Tas2r119 |
taste receptor, type 2, member 119 |
4660 |
0.24 |
chr4_148151043_148152234 | 13.14 |
Fbxo6 |
F-box protein 6 |
8 |
0.95 |
chr15_100614796_100615700 | 13.13 |
Dazap2 |
DAZ associated protein 2 |
101 |
0.53 |
chr15_7398044_7398852 | 13.13 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
53 |
0.91 |
chr8_4212633_4214018 | 13.09 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr17_56148877_56149316 | 13.07 |
Sema6b |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
8753 |
0.09 |
chr13_83721535_83721983 | 13.06 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
378 |
0.8 |
chr6_85502936_85503307 | 13.04 |
Fbxo41 |
F-box protein 41 |
127 |
0.94 |
chr14_4498574_4499972 | 13.03 |
Gm3173 |
predicted gene 3173 |
15485 |
0.11 |
chr2_25125625_25126488 | 12.99 |
AL732309.1 |
exonuclease 3'-5' domain containing 3 (EXD3) pseudogene |
9775 |
0.08 |
chr14_34896691_34896909 | 12.98 |
Mir346 |
microRNA 346 |
2191 |
0.38 |
chr14_55029006_55029605 | 12.97 |
Ngdn |
neuroguidin, EIF4E binding protein |
7883 |
0.07 |
chr4_65839396_65839998 | 12.97 |
Trim32 |
tripartite motif-containing 32 |
234448 |
0.02 |
chr6_42709318_42710223 | 12.95 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
301 |
0.81 |
chr9_40685777_40686641 | 12.95 |
Clmp |
CXADR-like membrane protein |
174 |
0.9 |
chr5_112239158_112239879 | 12.93 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
10123 |
0.11 |
chr9_43699339_43700154 | 12.92 |
Gm5364 |
predicted gene 5364 |
16693 |
0.14 |
chr7_43489442_43490064 | 12.89 |
Iglon5 |
IgLON family member 5 |
322 |
0.72 |
chr17_47887715_47888346 | 12.89 |
Foxp4 |
forkhead box P4 |
120 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.6 | 49.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
15.3 | 45.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
14.4 | 43.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
14.3 | 57.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
13.8 | 41.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
13.6 | 40.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
13.5 | 40.4 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
11.9 | 11.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
11.6 | 34.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
11.6 | 11.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
10.7 | 53.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
10.6 | 10.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
9.9 | 99.0 | GO:0071625 | vocalization behavior(GO:0071625) |
9.1 | 27.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
8.8 | 17.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
8.8 | 44.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
8.6 | 34.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
8.4 | 8.4 | GO:0021550 | medulla oblongata development(GO:0021550) |
8.4 | 33.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
8.3 | 33.2 | GO:0007412 | axon target recognition(GO:0007412) |
8.0 | 8.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
8.0 | 72.1 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
8.0 | 32.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
8.0 | 23.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
7.9 | 23.7 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
7.8 | 23.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
7.8 | 38.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
7.7 | 23.2 | GO:0060594 | mammary gland specification(GO:0060594) |
7.7 | 23.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
7.5 | 15.0 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
7.5 | 52.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
7.5 | 59.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
7.5 | 37.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
7.3 | 21.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
7.2 | 29.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
7.2 | 14.5 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
7.2 | 14.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
7.2 | 43.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
7.0 | 20.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
6.9 | 27.4 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
6.8 | 33.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
6.8 | 6.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
6.8 | 20.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
6.7 | 20.2 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
6.7 | 6.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
6.7 | 20.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
6.7 | 13.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
6.7 | 13.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
6.6 | 19.8 | GO:0061743 | motor learning(GO:0061743) |
6.5 | 52.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
6.5 | 12.9 | GO:0021564 | vagus nerve development(GO:0021564) |
6.4 | 25.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
6.3 | 12.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
6.2 | 25.0 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
6.2 | 31.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
6.2 | 49.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
6.2 | 49.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
6.1 | 67.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
6.1 | 30.3 | GO:0035989 | tendon development(GO:0035989) |
6.1 | 18.2 | GO:0001927 | exocyst assembly(GO:0001927) |
6.0 | 18.1 | GO:0097503 | sialylation(GO:0097503) |
6.0 | 6.0 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
6.0 | 102.1 | GO:0008038 | neuron recognition(GO:0008038) |
5.9 | 17.8 | GO:0021586 | pons maturation(GO:0021586) |
5.9 | 17.6 | GO:0030070 | insulin processing(GO:0030070) |
5.8 | 23.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
5.8 | 17.4 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
5.8 | 11.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
5.7 | 23.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
5.7 | 17.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
5.6 | 11.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
5.6 | 11.2 | GO:0060166 | olfactory pit development(GO:0060166) |
5.6 | 66.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
5.5 | 11.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
5.5 | 16.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
5.5 | 16.4 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
5.4 | 10.9 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
5.3 | 16.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
5.3 | 15.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
5.3 | 15.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
5.2 | 5.2 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
5.2 | 10.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
5.2 | 15.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
5.1 | 15.4 | GO:0072104 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
5.1 | 10.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
5.1 | 15.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
5.0 | 30.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
5.0 | 15.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
4.9 | 9.8 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
4.9 | 53.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
4.9 | 14.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
4.9 | 14.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.8 | 14.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
4.8 | 9.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
4.8 | 14.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
4.8 | 9.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
4.8 | 23.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
4.8 | 285.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
4.7 | 94.8 | GO:0001964 | startle response(GO:0001964) |
4.7 | 23.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
4.7 | 23.5 | GO:0046958 | nonassociative learning(GO:0046958) |
4.7 | 9.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
4.7 | 4.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
4.7 | 14.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
4.6 | 13.9 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
4.6 | 9.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
4.6 | 9.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
4.6 | 9.1 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
4.5 | 13.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
4.5 | 9.0 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
4.5 | 17.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
4.5 | 8.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
4.4 | 17.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
4.4 | 4.4 | GO:0021557 | oculomotor nerve development(GO:0021557) |
4.4 | 22.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
4.4 | 4.4 | GO:0048382 | mesendoderm development(GO:0048382) |
4.4 | 13.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
4.4 | 4.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
4.4 | 21.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
4.3 | 13.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
4.3 | 25.7 | GO:0010996 | response to auditory stimulus(GO:0010996) |
4.3 | 12.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
4.3 | 8.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
4.2 | 34.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
4.2 | 34.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
4.2 | 12.7 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
4.2 | 8.5 | GO:0048880 | sensory system development(GO:0048880) |
4.2 | 12.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
4.2 | 8.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
4.2 | 12.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
4.2 | 4.2 | GO:0014819 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) regulation of skeletal muscle contraction(GO:0014819) |
4.1 | 16.6 | GO:0051794 | regulation of catagen(GO:0051794) |
4.1 | 20.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
4.1 | 4.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
4.1 | 8.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
4.0 | 8.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
4.0 | 12.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
4.0 | 8.0 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
4.0 | 15.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
4.0 | 15.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
3.9 | 23.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
3.9 | 31.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
3.9 | 15.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
3.9 | 11.6 | GO:0060004 | reflex(GO:0060004) |
3.9 | 7.7 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
3.9 | 7.7 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
3.8 | 7.7 | GO:0048664 | neuron fate determination(GO:0048664) |
3.8 | 41.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
3.8 | 64.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
3.7 | 18.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
3.7 | 18.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.7 | 55.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
3.7 | 7.3 | GO:0090427 | activation of meiosis(GO:0090427) |
3.6 | 10.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
3.6 | 39.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
3.6 | 10.8 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
3.6 | 7.2 | GO:0008355 | olfactory learning(GO:0008355) |
3.6 | 14.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
3.6 | 21.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
3.6 | 25.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
3.5 | 10.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
3.5 | 6.9 | GO:0001757 | somite specification(GO:0001757) |
3.5 | 10.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
3.5 | 10.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.4 | 58.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
3.4 | 58.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
3.4 | 20.5 | GO:0022038 | corpus callosum development(GO:0022038) |
3.4 | 10.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
3.4 | 13.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.4 | 10.2 | GO:0030035 | microspike assembly(GO:0030035) |
3.4 | 57.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
3.4 | 10.1 | GO:0060005 | vestibular reflex(GO:0060005) |
3.4 | 16.8 | GO:0045759 | negative regulation of action potential(GO:0045759) |
3.3 | 13.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
3.3 | 10.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.3 | 3.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
3.3 | 10.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
3.3 | 6.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
3.3 | 3.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.3 | 26.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
3.3 | 9.8 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
3.2 | 9.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
3.2 | 3.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.2 | 19.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
3.2 | 6.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
3.2 | 6.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
3.2 | 35.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
3.2 | 16.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
3.2 | 19.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
3.2 | 3.2 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
3.1 | 31.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.1 | 3.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
3.1 | 189.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
3.1 | 15.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
3.1 | 6.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
3.1 | 6.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
3.1 | 6.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
3.1 | 6.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
3.1 | 15.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
3.0 | 12.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
3.0 | 12.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
3.0 | 3.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
3.0 | 6.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
3.0 | 15.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
3.0 | 5.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
3.0 | 3.0 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
3.0 | 14.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.9 | 8.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
2.9 | 5.9 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
2.9 | 14.7 | GO:0003416 | endochondral bone growth(GO:0003416) |
2.9 | 8.8 | GO:0048570 | notochord morphogenesis(GO:0048570) |
2.9 | 2.9 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
2.9 | 11.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.9 | 8.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.8 | 5.7 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
2.8 | 25.5 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
2.8 | 5.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
2.8 | 5.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.8 | 5.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
2.8 | 19.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
2.8 | 25.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
2.8 | 5.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
2.8 | 8.3 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.8 | 11.0 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
2.7 | 10.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
2.7 | 8.2 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
2.7 | 8.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
2.7 | 8.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
2.7 | 13.6 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.7 | 5.4 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
2.7 | 10.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.7 | 5.3 | GO:0090135 | actin filament branching(GO:0090135) |
2.7 | 13.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
2.7 | 29.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
2.7 | 5.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
2.7 | 37.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
2.6 | 44.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.6 | 12.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
2.5 | 10.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
2.5 | 5.0 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
2.5 | 2.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
2.5 | 2.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
2.5 | 64.7 | GO:0019228 | neuronal action potential(GO:0019228) |
2.5 | 9.9 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.5 | 4.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
2.5 | 2.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
2.4 | 22.0 | GO:0060384 | innervation(GO:0060384) |
2.4 | 4.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
2.4 | 4.9 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
2.4 | 7.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.4 | 9.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.4 | 9.5 | GO:2001023 | regulation of response to drug(GO:2001023) |
2.4 | 9.5 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
2.4 | 7.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
2.4 | 16.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
2.4 | 11.8 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
2.3 | 14.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
2.3 | 4.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.3 | 2.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
2.3 | 4.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
2.3 | 2.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
2.3 | 4.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.3 | 33.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
2.2 | 9.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.2 | 2.2 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.2 | 13.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
2.2 | 6.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
2.2 | 8.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.2 | 2.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
2.2 | 24.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
2.2 | 13.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.2 | 6.5 | GO:0060179 | male mating behavior(GO:0060179) |
2.2 | 4.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
2.1 | 4.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.1 | 4.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
2.1 | 6.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
2.1 | 2.1 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
2.1 | 6.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.1 | 4.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.1 | 14.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
2.1 | 2.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
2.0 | 2.0 | GO:0021764 | amygdala development(GO:0021764) |
2.0 | 6.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.0 | 8.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
2.0 | 2.0 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
2.0 | 12.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
2.0 | 8.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.0 | 12.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
2.0 | 4.0 | GO:0021854 | hypothalamus development(GO:0021854) |
2.0 | 6.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.0 | 3.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
2.0 | 5.9 | GO:0060437 | lung growth(GO:0060437) |
1.9 | 9.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.9 | 5.8 | GO:0033762 | response to glucagon(GO:0033762) |
1.9 | 5.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.9 | 9.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.9 | 5.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.9 | 1.9 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
1.9 | 11.6 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
1.9 | 7.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.9 | 9.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.9 | 7.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.9 | 5.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.9 | 1.9 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.9 | 5.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.9 | 5.7 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.9 | 9.4 | GO:0015884 | folic acid transport(GO:0015884) |
1.9 | 1.9 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
1.9 | 1.9 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
1.9 | 5.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.8 | 1.8 | GO:0033058 | directional locomotion(GO:0033058) |
1.8 | 5.5 | GO:0021984 | adenohypophysis development(GO:0021984) |
1.8 | 3.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.8 | 5.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.8 | 1.8 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.8 | 1.8 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.8 | 3.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.8 | 8.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.8 | 3.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.8 | 1.8 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.8 | 7.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.7 | 10.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.7 | 1.7 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
1.7 | 13.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.7 | 5.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.7 | 18.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
1.7 | 3.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.7 | 5.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.7 | 18.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.7 | 6.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.7 | 20.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
1.7 | 3.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.7 | 3.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.6 | 6.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.6 | 3.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.6 | 6.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.6 | 4.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.6 | 23.0 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
1.6 | 4.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.6 | 3.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.6 | 6.5 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.6 | 9.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.6 | 1.6 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.6 | 4.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.6 | 122.6 | GO:0097485 | neuron projection guidance(GO:0097485) |
1.6 | 1.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.6 | 6.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.6 | 17.4 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
1.6 | 6.3 | GO:0030091 | protein repair(GO:0030091) |
1.6 | 7.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.6 | 1.6 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.6 | 3.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
1.6 | 6.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
1.5 | 49.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.5 | 10.8 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
1.5 | 4.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.5 | 1.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.5 | 1.5 | GO:0060161 | receptor-mediated endocytosis of virus by host cell(GO:0019065) positive regulation of dopamine receptor signaling pathway(GO:0060161) endocytosis involved in viral entry into host cell(GO:0075509) |
1.5 | 10.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.5 | 7.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.5 | 7.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.5 | 1.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.5 | 11.8 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
1.5 | 10.4 | GO:0006108 | malate metabolic process(GO:0006108) |
1.5 | 3.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
1.5 | 1.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
1.5 | 1.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.5 | 2.9 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.5 | 4.4 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.5 | 2.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.4 | 7.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.4 | 1.4 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
1.4 | 8.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.4 | 19.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.4 | 1.4 | GO:0072174 | metanephric tubule formation(GO:0072174) |
1.4 | 17.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.4 | 1.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
1.4 | 4.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.4 | 1.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.4 | 1.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.4 | 1.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.4 | 1.4 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.4 | 1.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.4 | 4.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.4 | 2.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.4 | 5.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.4 | 5.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.4 | 2.7 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.4 | 8.1 | GO:0060736 | prostate gland growth(GO:0060736) |
1.4 | 10.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
1.3 | 6.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.3 | 4.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
1.3 | 10.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
1.3 | 2.7 | GO:0061055 | myotome development(GO:0061055) |
1.3 | 4.0 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
1.3 | 5.3 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.3 | 2.7 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.3 | 2.7 | GO:0090383 | phagosome acidification(GO:0090383) |
1.3 | 133.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.3 | 9.0 | GO:0010842 | retina layer formation(GO:0010842) |
1.3 | 5.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.3 | 3.8 | GO:0061511 | centriole elongation(GO:0061511) |
1.3 | 5.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.3 | 2.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.3 | 1.3 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
1.2 | 1.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
1.2 | 2.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.2 | 6.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.2 | 2.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
1.2 | 2.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
1.2 | 1.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.2 | 4.9 | GO:0050961 | sensory perception of temperature stimulus(GO:0050951) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.2 | 1.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.2 | 1.2 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.2 | 2.4 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.2 | 3.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.2 | 3.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.2 | 7.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.2 | 4.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.2 | 4.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.2 | 1.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.2 | 4.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.2 | 2.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.2 | 2.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.2 | 80.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
1.1 | 1.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.1 | 2.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.1 | 6.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.1 | 1.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
1.1 | 4.5 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
1.1 | 3.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.1 | 2.3 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
1.1 | 7.9 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.1 | 3.4 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.1 | 2.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.1 | 1.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.1 | 3.3 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
1.1 | 14.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
1.1 | 3.3 | GO:0050955 | thermoception(GO:0050955) |
1.1 | 15.2 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
1.1 | 1.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.1 | 3.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.1 | 1.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.1 | 3.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 3.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.1 | 1.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.1 | 3.2 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.1 | 2.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.1 | 1.1 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
1.0 | 2.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.0 | 3.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.0 | 3.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.0 | 1.0 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
1.0 | 11.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.0 | 26.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
1.0 | 2.0 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
1.0 | 9.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.0 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.0 | 26.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
1.0 | 6.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
1.0 | 3.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.0 | 3.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.0 | 2.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.0 | 2.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.0 | 2.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.0 | 2.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.0 | 1.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
1.0 | 2.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.0 | 2.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.0 | 4.8 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.0 | 6.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.9 | 15.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.9 | 14.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.9 | 5.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.9 | 1.8 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.9 | 0.9 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.9 | 2.7 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.9 | 1.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 1.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.9 | 1.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.9 | 11.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.9 | 3.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.9 | 6.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.9 | 2.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.9 | 1.8 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.9 | 4.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.9 | 2.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.9 | 0.9 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.9 | 0.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.9 | 2.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.9 | 3.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.9 | 1.7 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.9 | 8.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.9 | 1.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 1.7 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.9 | 5.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.9 | 3.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.9 | 1.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.9 | 4.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.8 | 2.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.8 | 1.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 2.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.8 | 9.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.8 | 2.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.8 | 4.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.8 | 3.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.8 | 1.6 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.8 | 0.8 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.8 | 1.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.8 | 3.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.8 | 3.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.8 | 3.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.8 | 4.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.8 | 0.8 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.8 | 3.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.8 | 0.8 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.8 | 1.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.8 | 3.0 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.8 | 3.8 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.8 | 3.8 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.8 | 4.5 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.8 | 3.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.8 | 1.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.7 | 1.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.7 | 2.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.7 | 1.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.7 | 1.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 1.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.7 | 2.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.7 | 2.1 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.7 | 2.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 1.4 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.7 | 10.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.7 | 6.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 2.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.7 | 0.7 | GO:0007494 | midgut development(GO:0007494) Peyer's patch morphogenesis(GO:0061146) |
0.7 | 3.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 1.4 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.7 | 1.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.7 | 2.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.7 | 2.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.7 | 2.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.7 | 2.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.6 | 3.9 | GO:0043586 | tongue development(GO:0043586) |
0.6 | 0.6 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.6 | 3.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 2.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 1.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 4.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.6 | 1.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.6 | 1.9 | GO:0014075 | response to amine(GO:0014075) |
0.6 | 2.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 1.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.6 | 4.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.6 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 1.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.6 | 8.0 | GO:0007416 | synapse assembly(GO:0007416) |
0.6 | 0.6 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.6 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.6 | 4.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.6 | 3.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.6 | 1.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.6 | 1.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.6 | 6.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.6 | 0.6 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 3.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.6 | 0.6 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.6 | 1.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.6 | 1.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.6 | 1.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 1.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.6 | 1.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 1.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 4.6 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.6 | 0.6 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.6 | 5.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 3.4 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.6 | 0.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.6 | 1.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 7.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.6 | 1.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.6 | 2.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 1.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.6 | 3.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.6 | 0.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.6 | 1.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.5 | 8.7 | GO:0008542 | visual learning(GO:0008542) |
0.5 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.5 | 1.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 4.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 1.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.5 | 1.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 2.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.5 | 1.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.5 | 9.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.5 | 1.6 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.5 | 1.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 1.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.5 | 0.5 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 3.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 3.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 1.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 1.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.5 | 1.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 4.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 2.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.5 | 5.1 | GO:0045056 | transcytosis(GO:0045056) |
0.5 | 1.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 1.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 0.5 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.5 | 2.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 2.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 3.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 4.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 1.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.5 | 1.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.5 | 1.0 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.5 | 1.4 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.5 | 1.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 0.9 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.5 | 1.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 2.4 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.5 | 0.5 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 0.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 3.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.5 | 1.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.4 | 1.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 4.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.4 | 1.8 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.4 | 1.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 3.1 | GO:0007135 | meiosis II(GO:0007135) |
0.4 | 0.4 | GO:0032277 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.4 | 0.9 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.4 | 1.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 0.9 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.4 | 1.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 0.4 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 0.8 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.4 | 1.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 1.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 1.2 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 2.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 1.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.4 | 0.8 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.4 | 3.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.4 | 0.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 2.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.4 | 0.8 | GO:0060452 | positive regulation of striated muscle contraction(GO:0045989) positive regulation of cardiac muscle contraction(GO:0060452) |
0.4 | 0.4 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.4 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 5.3 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.4 | 0.4 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.4 | 1.1 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.4 | 0.7 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.4 | 1.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 0.4 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.4 | 0.7 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 3.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.4 | 1.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 3.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 16.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 1.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 2.4 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.3 | 0.7 | GO:0015872 | dopamine transport(GO:0015872) |
0.3 | 2.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 0.7 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 5.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 1.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 2.2 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 0.6 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 20.9 | GO:0007626 | locomotory behavior(GO:0007626) |
0.3 | 3.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 1.8 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 1.8 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 2.7 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 2.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.3 | 0.9 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 3.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.3 | 0.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 0.3 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 11.0 | GO:0001764 | neuron migration(GO:0001764) |
0.3 | 0.6 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 0.6 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.3 | 1.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 0.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.3 | 1.6 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 0.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 1.6 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.3 | 1.3 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.3 | 0.5 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 2.1 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 6.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.3 | 1.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 1.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 1.0 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.7 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.2 | 0.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.2 | GO:0035482 | gastric motility(GO:0035482) |
0.2 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.2 | GO:0032835 | glomerulus development(GO:0032835) |
0.2 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.9 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 1.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.2 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.2 | 1.7 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.8 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.8 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.2 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 0.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 1.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.2 | GO:0032632 | interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) |
0.2 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.2 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.2 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 0.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.2 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.2 | 1.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 2.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.4 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 1.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 1.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.9 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.7 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.7 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.1 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 0.2 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 1.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.6 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.0 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.0 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 2.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.0 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.0 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 36.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
8.9 | 8.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
8.5 | 25.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
7.5 | 37.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
7.3 | 50.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
6.8 | 47.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
6.7 | 6.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
6.6 | 73.0 | GO:0043194 | axon initial segment(GO:0043194) |
6.4 | 76.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
6.1 | 110.5 | GO:0030673 | axolemma(GO:0030673) |
6.1 | 18.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
5.8 | 69.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
5.7 | 17.2 | GO:0072534 | perineuronal net(GO:0072534) |
5.5 | 16.4 | GO:0044308 | axonal spine(GO:0044308) |
5.4 | 134.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
5.4 | 21.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.3 | 16.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
5.2 | 88.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
5.2 | 46.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
5.1 | 15.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
5.0 | 34.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.7 | 23.6 | GO:0043083 | synaptic cleft(GO:0043083) |
4.6 | 128.9 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
4.6 | 136.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
4.3 | 17.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
4.1 | 24.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
4.1 | 40.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
4.0 | 32.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
4.0 | 24.1 | GO:0005915 | zonula adherens(GO:0005915) |
4.0 | 12.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
4.0 | 44.0 | GO:0001527 | microfibril(GO:0001527) |
3.9 | 11.6 | GO:0097427 | microtubule bundle(GO:0097427) |
3.8 | 26.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
3.8 | 11.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
3.6 | 110.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.5 | 14.0 | GO:1990696 | USH2 complex(GO:1990696) |
3.5 | 13.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
3.3 | 3.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
3.2 | 9.6 | GO:0043511 | inhibin complex(GO:0043511) |
3.0 | 3.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.0 | 3.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
3.0 | 162.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.9 | 34.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.8 | 2.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.6 | 58.0 | GO:0044295 | axonal growth cone(GO:0044295) |
2.5 | 7.6 | GO:0048179 | activin receptor complex(GO:0048179) |
2.5 | 7.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.4 | 332.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.3 | 9.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
2.3 | 14.0 | GO:0032584 | growth cone membrane(GO:0032584) |
2.2 | 11.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.2 | 6.5 | GO:0043205 | fibril(GO:0043205) |
2.1 | 12.6 | GO:0044327 | dendritic spine head(GO:0044327) |
2.1 | 26.7 | GO:0043196 | varicosity(GO:0043196) |
2.1 | 28.7 | GO:0044298 | cell body membrane(GO:0044298) |
2.0 | 8.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.0 | 10.0 | GO:0097433 | dense body(GO:0097433) |
2.0 | 7.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.9 | 7.7 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.9 | 23.1 | GO:0031045 | dense core granule(GO:0031045) |
1.9 | 1.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.9 | 5.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.9 | 17.0 | GO:0097542 | ciliary tip(GO:0097542) |
1.7 | 8.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.7 | 21.8 | GO:0034704 | calcium channel complex(GO:0034704) |
1.6 | 11.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.6 | 8.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.6 | 23.8 | GO:0005614 | interstitial matrix(GO:0005614) |
1.6 | 217.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.6 | 4.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.5 | 9.1 | GO:0044292 | dendrite terminus(GO:0044292) |
1.5 | 40.9 | GO:0043198 | dendritic shaft(GO:0043198) |
1.5 | 3.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.4 | 4.3 | GO:0000322 | storage vacuole(GO:0000322) |
1.4 | 12.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.4 | 8.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.4 | 85.8 | GO:0043195 | terminal bouton(GO:0043195) |
1.3 | 5.3 | GO:0070545 | PeBoW complex(GO:0070545) |
1.3 | 3.9 | GO:0033010 | paranodal junction(GO:0033010) |
1.3 | 105.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
1.3 | 3.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.2 | 11.2 | GO:0032433 | filopodium tip(GO:0032433) |
1.2 | 2.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.2 | 86.2 | GO:0030426 | growth cone(GO:0030426) |
1.2 | 1.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.1 | 3.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.1 | 2.2 | GO:0097441 | basilar dendrite(GO:0097441) |
1.0 | 4.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.0 | 6.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.0 | 5.1 | GO:0032590 | dendrite membrane(GO:0032590) |
1.0 | 28.1 | GO:0005921 | gap junction(GO:0005921) |
0.9 | 8.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.9 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.9 | 3.6 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.9 | 2.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.9 | 2.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.9 | 54.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.9 | 223.4 | GO:0045202 | synapse(GO:0045202) |
0.8 | 2.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.8 | 7.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 7.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 0.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.8 | 6.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.8 | 4.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.8 | 2.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.8 | 2.3 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 2.2 | GO:0071437 | invadopodium(GO:0071437) invadopodium membrane(GO:0071438) |
0.7 | 2.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.7 | 27.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.7 | 2.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 20.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.7 | 36.0 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 159.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.7 | 16.2 | GO:0016235 | aggresome(GO:0016235) |
0.7 | 2.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 1.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 4.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.6 | 2.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 3.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.6 | 8.4 | GO:0030904 | retromer complex(GO:0030904) |
0.5 | 8.6 | GO:0030057 | desmosome(GO:0030057) |
0.5 | 1.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.5 | 1.5 | GO:0030427 | site of polarized growth(GO:0030427) |
0.5 | 1.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 3.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 1.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 2.9 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.5 | 1.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.4 | 15.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.4 | 6.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 15.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.4 | 4.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 2.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.4 | 0.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 5.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 3.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 2.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.6 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 4.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 2.2 | GO:0044447 | axoneme part(GO:0044447) |
0.3 | 2.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 1.2 | GO:0001652 | granular component(GO:0001652) |
0.3 | 3.1 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 3.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 1.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 1.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 1.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 2.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 2.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 2.0 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.5 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 6.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 2.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.2 | 48.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
13.3 | 40.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
12.9 | 38.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
11.7 | 35.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
10.9 | 65.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
10.7 | 53.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
10.6 | 31.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
10.0 | 30.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
9.2 | 18.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
9.0 | 36.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
8.8 | 61.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
8.2 | 57.1 | GO:0003680 | AT DNA binding(GO:0003680) |
8.0 | 24.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
8.0 | 23.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
7.9 | 39.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
7.5 | 22.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
7.5 | 37.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
6.9 | 20.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
6.6 | 32.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
6.5 | 26.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
6.4 | 19.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
6.4 | 19.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
6.4 | 25.6 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
5.7 | 28.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
5.5 | 54.7 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
5.4 | 21.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
5.4 | 16.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
5.3 | 16.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
5.3 | 100.9 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
5.0 | 14.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
4.9 | 19.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.9 | 19.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
4.7 | 28.1 | GO:0048495 | Roundabout binding(GO:0048495) |
4.7 | 18.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
4.6 | 18.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
4.5 | 53.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
4.4 | 30.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
4.3 | 21.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
4.2 | 12.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
4.1 | 45.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.1 | 32.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
4.1 | 12.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
4.0 | 12.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
4.0 | 19.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.9 | 7.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
3.8 | 115.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
3.8 | 15.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
3.7 | 73.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
3.6 | 17.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
3.6 | 14.3 | GO:0097001 | ceramide binding(GO:0097001) |
3.5 | 49.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
3.5 | 10.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
3.4 | 17.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
3.4 | 10.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
3.4 | 6.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
3.4 | 10.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
3.3 | 6.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
3.3 | 6.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
3.2 | 12.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
3.2 | 6.4 | GO:0097016 | L27 domain binding(GO:0097016) |
3.2 | 73.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
3.1 | 15.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.0 | 9.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
3.0 | 12.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
3.0 | 12.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.9 | 14.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.9 | 17.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.9 | 108.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
2.9 | 8.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.9 | 8.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.9 | 14.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.9 | 69.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.9 | 34.6 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
2.9 | 85.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.8 | 36.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
2.8 | 5.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
2.8 | 5.5 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
2.7 | 32.8 | GO:0031005 | filamin binding(GO:0031005) |
2.7 | 8.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
2.7 | 13.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
2.7 | 8.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.6 | 13.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.6 | 2.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.5 | 15.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.5 | 20.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.5 | 54.9 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
2.5 | 14.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.5 | 7.5 | GO:0038100 | nodal binding(GO:0038100) |
2.4 | 9.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.4 | 12.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.4 | 4.8 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
2.4 | 50.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.3 | 7.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.3 | 16.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.3 | 6.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
2.3 | 11.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.3 | 9.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.2 | 4.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.2 | 20.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
2.2 | 6.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.2 | 23.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
2.1 | 10.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
2.1 | 17.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
2.1 | 33.0 | GO:0015026 | coreceptor activity(GO:0015026) |
2.1 | 8.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
2.1 | 8.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.0 | 6.1 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.0 | 6.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.0 | 11.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.0 | 23.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.0 | 27.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.9 | 13.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.9 | 7.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.9 | 15.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.9 | 5.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.9 | 5.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.9 | 47.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.9 | 50.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.9 | 7.4 | GO:0048185 | activin binding(GO:0048185) |
1.8 | 5.4 | GO:0055100 | adiponectin binding(GO:0055100) |
1.8 | 5.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.8 | 3.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.8 | 14.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.8 | 26.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.7 | 57.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.7 | 10.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.7 | 5.2 | GO:0042731 | PH domain binding(GO:0042731) |
1.7 | 8.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.7 | 10.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.7 | 6.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.7 | 8.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.7 | 6.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.6 | 9.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.6 | 3.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.6 | 8.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.6 | 8.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.6 | 14.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.6 | 18.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.5 | 7.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.5 | 13.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.5 | 4.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.5 | 6.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
1.5 | 5.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.5 | 5.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.5 | 4.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.5 | 4.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.5 | 4.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.4 | 5.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.4 | 18.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.4 | 5.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.4 | 5.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.4 | 31.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.4 | 4.1 | GO:0051373 | FATZ binding(GO:0051373) |
1.4 | 6.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.3 | 6.6 | GO:1990254 | keratin filament binding(GO:1990254) |
1.3 | 3.9 | GO:0016015 | morphogen activity(GO:0016015) |
1.3 | 2.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.3 | 5.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.3 | 7.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.3 | 7.7 | GO:0042805 | actinin binding(GO:0042805) |
1.3 | 11.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.3 | 15.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.3 | 11.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.2 | 5.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.2 | 1.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.2 | 2.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.2 | 15.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.2 | 14.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.2 | 2.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.2 | 16.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.2 | 12.8 | GO:0005522 | profilin binding(GO:0005522) |
1.2 | 4.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.2 | 3.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.2 | 2.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.2 | 3.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.2 | 2.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.1 | 12.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.1 | 2.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
1.1 | 7.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.1 | 41.2 | GO:0018721 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
1.1 | 19.8 | GO:0003785 | actin monomer binding(GO:0003785) |
1.1 | 6.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.1 | 5.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.1 | 33.8 | GO:0005109 | frizzled binding(GO:0005109) |
1.1 | 3.3 | GO:0070052 | collagen V binding(GO:0070052) |
1.1 | 2.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.1 | 27.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.0 | 41.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
1.0 | 17.2 | GO:0005112 | Notch binding(GO:0005112) |
1.0 | 5.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.0 | 15.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
1.0 | 5.0 | GO:0034711 | inhibin binding(GO:0034711) |
1.0 | 5.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.0 | 5.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.0 | 6.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.0 | 53.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.0 | 3.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 20.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.0 | 1.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.0 | 2.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.9 | 1.9 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.9 | 2.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.9 | 3.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 4.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 4.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.9 | 90.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.9 | 22.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.9 | 2.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.9 | 2.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.9 | 2.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.8 | 8.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.8 | 8.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 5.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.8 | 17.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 10.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.8 | 4.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.8 | 7.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 2.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.8 | 10.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.8 | 4.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.8 | 5.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.8 | 6.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.8 | 2.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.8 | 3.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.7 | 3.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 5.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.7 | 2.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.7 | 2.9 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.7 | 20.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.7 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.7 | 2.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 9.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.7 | 3.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.7 | 2.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.7 | 2.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.7 | 2.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 3.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 2.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 8.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.7 | 2.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.7 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.7 | 14.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 3.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 2.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 2.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.7 | 58.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.7 | 2.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 2.6 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.6 | 1.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 1.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.6 | 2.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.6 | 1.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.6 | 5.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 21.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.6 | 4.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 8.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 1.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 15.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.6 | 7.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 2.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 1.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.6 | 1.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.6 | 2.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 2.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 3.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 2.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 5.5 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.5 | 1.6 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.5 | 1.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.5 | 23.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.5 | 6.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.5 | 5.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 3.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.5 | 119.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.5 | 2.6 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 1.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 2.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 2.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.5 | 2.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 1.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 2.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 3.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 3.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 1.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 3.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.4 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 3.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.4 | 177.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.4 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 1.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 0.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 2.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 1.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 3.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 1.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 0.4 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.4 | 2.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 1.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 1.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 1.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 0.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 2.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 19.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 3.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 8.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 1.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 1.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 2.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 1.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.3 | 1.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 3.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 3.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 5.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 0.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 0.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 4.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.3 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 1.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 6.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.3 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 1.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 2.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 1.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.7 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 4.6 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 1.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 3.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.2 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 80.2 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.2 | 1.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.6 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 1.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 1.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 1.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.6 | GO:0044653 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 9.4 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 19.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
4.0 | 4.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
4.0 | 75.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
3.8 | 122.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
3.4 | 6.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
3.1 | 46.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
3.1 | 73.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
3.0 | 6.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.7 | 13.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
2.6 | 20.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.6 | 112.4 | NABA COLLAGENS | Genes encoding collagen proteins |
2.6 | 30.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.5 | 17.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
2.3 | 73.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.6 | 35.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.6 | 18.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.5 | 52.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.5 | 10.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.5 | 38.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.4 | 42.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.4 | 17.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.3 | 26.5 | PID REELIN PATHWAY | Reelin signaling pathway |
1.3 | 1.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.2 | 214.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.1 | 5.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.1 | 2.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.0 | 10.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.9 | 0.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 12.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.9 | 30.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.9 | 7.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 9.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.8 | 6.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.8 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.7 | 95.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 2.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.7 | 14.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 3.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 10.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 3.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 115.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 5.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 2.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 1.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 1.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 6.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 2.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 1.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 2.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 2.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 25.0 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 7.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
6.8 | 81.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
6.0 | 89.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
5.2 | 72.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
4.9 | 68.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
4.7 | 14.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
4.6 | 4.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
4.5 | 40.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
4.4 | 170.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
4.3 | 110.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
4.2 | 179.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.7 | 84.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
3.6 | 39.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.5 | 14.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.5 | 45.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
3.4 | 37.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
3.3 | 56.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.2 | 3.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
3.1 | 58.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.1 | 6.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.9 | 23.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.9 | 67.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
2.9 | 37.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
2.8 | 11.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
2.8 | 64.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
2.3 | 18.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.2 | 24.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.0 | 73.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.9 | 25.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.9 | 22.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.8 | 24.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.8 | 3.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.7 | 5.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.7 | 24.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
1.7 | 10.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
1.6 | 4.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
1.5 | 10.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.5 | 24.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.5 | 33.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.5 | 19.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.4 | 12.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.3 | 5.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.3 | 14.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.3 | 1.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.2 | 40.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.2 | 7.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.2 | 3.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.2 | 5.8 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
1.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.1 | 5.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.1 | 1.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.0 | 18.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.0 | 3.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.0 | 1.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.0 | 9.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.0 | 10.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.9 | 9.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.9 | 0.9 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.9 | 10.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.9 | 31.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 56.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.8 | 8.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.8 | 6.6 | REACTOME OPSINS | Genes involved in Opsins |
0.8 | 7.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.8 | 8.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.8 | 13.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.8 | 7.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 10.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.7 | 15.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 6.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 5.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 2.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.7 | 7.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.7 | 2.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 3.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 4.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 11.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 7.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.6 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.5 | 11.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 10.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.5 | 8.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 0.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 5.8 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.4 | 7.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 5.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 10.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 0.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 7.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 1.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 2.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 3.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 2.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 3.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 1.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 16.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |